ELOIRA | Extremely effective (99.8%) |
COPPER IUD (Cu 250) | Extremely effective (99%) |
COPPER IUD (Cu 375) | Extremely effective (99%) |
COPPER IUD (TCu 380A) | Extremely effective (99%) |
ORAL CONTRACEPTIVE PILLS | Very effective (92%) |
INJECTABLE CONTRACEPTIVES | Very effective (97%) |
ABSTINENCE | Extemely effective (100%) |
FEMALE STERILIZATION | Extremely effective (99%) |
LACTATIONAL AMENORRHEA METHOD | Extremely effective (98 - 99%) |
VASECTOMY | Extremely effective (99%) |
VAGINAL RING | Very effective (92%) |
FEMALE CONDOM | Effective (79%) |
MALE CONDOM | Effective (85%) |
WITHDRAWAL | Effective (82%) |
EMERGENCY CONTRACEPTION | Moderately effective (75 - 89%) |
FERTILITY AWARENESS METHODS | Moderately effective (75%) |
SPERMICIDE | Moderately effective (75%) |
SPONGE | Moderately effective (68 - 84%) |
ELOIRA | Effective for 5 years |
COPPER IUD (Cu 250) | Effective for 3 years |
COPPER IUD (Cu 375) | Effective for 5 years |
COPPER IUD (TCu 380A) | Effective for 10 years |
ORAL CONTRACEPTIVE PILLS | Take daily |
INJECTABLE CONTRACEPTIVES | Effective for 3 months |
ABSTINENCE | Not applicable |
FEMALE STERILIZATION | Permanent |
LACTATIONAL AMENORRHEA METHOD | Daily for 6 months after delivery of baby |
VASECTOMY | Permanent |
VAGINAL RING | Replace monthly |
FEMALE CONDOM | Use and dispose with each act of intercourse |
MALE CONDOM | Use and dispose with each act of intercourse |
WITHDRAWAL | Use with each act of intercourse |
EMERGENCY CONTRACEPTION | Can be taken up to 3 days after unprotected sex |
FERTILITY AWARENESS METHODS | Track daily |
SPERMICIDE | Use with each act of intercourse |
SPONGE | Dispose of 24 hours after insertion |
ELOIRA | Irregular or no periods |
COPPER IUD (Cu 250) | Heavier periods, increased cramping |
COPPER IUD (Cu 375) | Heavier periods, increased cramping |
COPPER IUD (TCu 380A) | Heavier periods, increased cramping |
ORAL CONTRACEPTIVE PILLS | Nausea, headaches, breast tenderness |
INJECTABLE CONTRACEPTIVES | Irregular or no periods, weight gain |
ABSTINENCE | None |
FEMALE STERILIZATION | Potential complications associated with anesthesia and surgery; cramping, pain, bleeding or spotting on day of procedure; perforation of the uterus and /or fallopian tube |
LACTATIONAL AMENORRHEA METHOD | None |
VASECTOMY | Short-term tenderness and bruising, reactions to local anesthesia, infection |
VAGINAL RING | Nausea, headaches, breast tenderness |
FEMALE CONDOM | None |
MALE CONDOM | Irritation from latex |
WITHDRAWAL | None |
EMERGENCY CONTRACEPTION | Nausea, irregular next period following use |
FERTILITY AWARENESS METHODS | None |
SPERMICIDE | Irritation from spermicide, increased risk of vaginal infection |
SPONGE | Irritation from spermicide, increased risk of vaginal infection |
ELOIRA | Yes |
COPPER IUD (Cu 250) | Yes |
COPPER IUD (Cu 375) | Yes |
COPPER IUD (TCu 380A) | Yes |
ORAL CONTRACEPTIVE PILLS | Yes |
INJECTABLE CONTRACEPTIVES | No |
ABSTINENCE | Not applicable |
FEMALE STERILIZATION | No |
LACTATIONAL AMENORRHEA METHOD | Yes |
VASECTOMY | No |
VAGINAL RING | Yes |
FEMALE CONDOM | Yes |
MALE CONDOM | Yes |
WITHDRAWAL | Yes |
EMERGENCY CONTRACEPTION | Yes |
FERTILITY AWARENESS METHODS | Yes |
SPERMICIDE | Yes |
SPONGE | Yes |